Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05487235
Title A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Genentech, Inc.
Indications

head and neck squamous cell carcinoma

lung non-small cell carcinoma

melanoma

Advanced Solid Tumor

Therapies

Atezolizumab + RLY-1971

Atezolizumab + Omeprazole + RLY-1971

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST